UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis

The New England journal of medicine, 2021-12, Vol.385 (25), p.2313-2324

2021

Volltextzugriff (PDF)

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis

The New England journal of medicine, 2021-12, Vol.385 (25), p.2325-2335

2021

Volltextzugriff (PDF)

Administration of parenteral iron and mortality among hemodialysis patients

Journal of the American Society of Nephrology, 2004-06, Vol.15 (6), p.1623-1632

2004

Volltextzugriff (PDF)

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure

Clinical kidney journal, 2019-10, Vol.12 (5), p.693-701

2019

Volltextzugriff (PDF)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects

Kidney international reports, 2018-07, Vol.3 (4), p.841-850

2018

Volltextzugriff (PDF)

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Kidney international reports, 2019-06, Vol.4 (6), p.864-872

2019

Volltextzugriff (PDF)

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects

Pharmacology research & perspectives, 2018-04, Vol.6 (2), p.e00327-n/a

2018

Volltextzugriff (PDF)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

BMC nephrology, 2018-06, Vol.19 (1), p.135-135, Article 135

2018

Volltextzugriff (PDF)

Nephrotic Syndrome after Hematopoietic Cell Transplantation: Do Glomerular Lesions Represent Renal Graft-versus-Host Disease?

Clinical journal of the American Society of Nephrology, 2006-07, Vol.1 (4), p.685-694

2006

Volltextzugriff (PDF)

The Costs and Benefits of Automatic Estimated Glomerular Filtration Rate Reporting

Clinical journal of the American Society of Nephrology, 2009-02, Vol.4 (2), p.419-427

2009

Volltextzugriff (PDF)

RELATIONSHIP BETWEEN DRAIN VOLUME/FILL VOLUME RATIO AND CLINICAL OUTCOMES ASSOCIATED WITH OVERFILL COMPLAINTS IN PERITONEAL DIALYSIS PATIENTS

Peritoneal dialysis international, 2011-03, Vol.31 (2), p.148-153

2011

Volltextzugriff (PDF)

P0862DAPRODUSTAT INTERACTION WITH PHOSPHATE BINDERS HAS MINIMAL IMPACT ON HEMOGLOBIN VALUES IN HEMODIALYSIS POPULATION

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Daprodustat Interaction with Phosphate Binders Has Minimal Impact on Hemoglobin Values in Hemodialysis Population: PO0293

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.141-141

2020

Volltextzugriff (PDF)

The Occurrence of Increased Intraperitoneal Volume Events in Automated Peritoneal Dialysis in the US: Role of Programming, Patient/User Actions and Ultrafiltration

Peritoneal dialysis international, 2014-06, Vol.34 (4), p.434-442

2014

Volltextzugriff (PDF)

MO751: Calciphylaxis is Characterized by Pyrophosphate Deficiency in Dialysis Patients: A Pilot Study

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Volltextzugriff (PDF)

SP343DAPRODUSTAT MAINTAINS HEMOGLOBIN LEVELS IN CKD SUBJECTS REQUIRING HIGHER ESA DOSES

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Volltextzugriff (PDF)

The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease

Kidney international, 2023-06, Vol.103 (6), p.1180-1192

2023

Volltextzugriff (PDF)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

Clinical kidney journal, 2019-02, Vol.12 (1), p.129-138

2019

Volltextzugriff (PDF)

SaO004OCULAR SAFETY PROFILE OF DAPRODUSTAT: RESULTS OF TWO 24 WEEK STUDIES

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i316-i316

2018

Volltextzugriff (PDF)

Effects of Daprodustat on Hemoglobin and Quality of Life in Patients with CKD: Results of the ASCEND-NHQ Randomized, Double-Blind, Placebo-Controlled Trial: FR-OR53

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.36-36

2021

Volltextzugriff (PDF)

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

Nephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.960-972

2022

Volltextzugriff (PDF)

Regional Variation of Erythropoietin-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D): TH-OR08

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.3-3

2020

Volltextzugriff (PDF)

SP340ANEMIA AND MORTALITY IN PATIENTS WITH NONDIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii225-iii225

2017

Volltextzugriff (PDF)

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

American journal of nephrology, 2023-05, Vol.54 (1-2), p.1-13

2023

Volltextzugriff (PDF)

The ASCEND-ND trial: study design and participant characteristics

Nephrology, dialysis, transplantation, 2022-10, Vol.37 (11), p.2157-2170

2022

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis

Administration of parenteral iron and mortality among hemodialysis patients

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

Nephrotic Syndrome after Hematopoietic Cell Transplantation: Do Glomerular Lesions Represent Renal Graft-versus-Host Disease?

The Costs and Benefits of Automatic Estimated Glomerular Filtration Rate Reporting

RELATIONSHIP BETWEEN DRAIN VOLUME/FILL VOLUME RATIO AND CLINICAL OUTCOMES ASSOCIATED WITH OVERFILL COMPLAINTS IN PERITONEAL DIALYSIS PATIENTS

P0862DAPRODUSTAT INTERACTION WITH PHOSPHATE BINDERS HAS MINIMAL IMPACT ON HEMOGLOBIN VALUES IN HEMODIALYSIS POPULATION

Daprodustat Interaction with Phosphate Binders Has Minimal Impact on Hemoglobin Values in Hemodialysis Population: PO0293

The Occurrence of Increased Intraperitoneal Volume Events in Automated Peritoneal Dialysis in the US: Role of Programming, Patient/User Actions and Ultrafiltration

MO751: Calciphylaxis is Characterized by Pyrophosphate Deficiency in Dialysis Patients: A Pilot Study

SP343DAPRODUSTAT MAINTAINS HEMOGLOBIN LEVELS IN CKD SUBJECTS REQUIRING HIGHER ESA DOSES

The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

SaO004OCULAR SAFETY PROFILE OF DAPRODUSTAT: RESULTS OF TWO 24 WEEK STUDIES

Effects of Daprodustat on Hemoglobin and Quality of Life in Patients with CKD: Results of the ASCEND-NHQ Randomized, Double-Blind, Placebo-Controlled Trial: FR-OR53

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

Regional Variation of Erythropoietin-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D): TH-OR08

SP340ANEMIA AND MORTALITY IN PATIENTS WITH NONDIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

The ASCEND-ND trial: study design and participant characteristics

Aktive Filter

Suchergebnisse filtern